Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-542X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients ; volume:20 ; number:1 ; day:16 ; month:5 ; year:2018 ; pages:1-5 ; date:12.2018
Breast cancer research ; 20, Heft 1 (16.5.2018), 1-5, 12.2018

Creator: Allouchery, Violette

Contributor: Beaussire, Ludivine
Perdrix, Anne
Sefrioui, David
Augusto, Laetitia
Guillemet, Cécile
Sarafan-Vasseur, Nasrin
Di Fiore, Frédéric
Clatot, Florian
SpringerLink (Online service)

DOI: 10.1186/s13058-018-0968-0

URN: urn:nbn:de:101:1-2018072217064638485980

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Allouchery, Violette
Beaussire, Ludivine
Perdrix, Anne
Sefrioui, David
Augusto, Laetitia
Guillemet, Cécile
Sarafan-Vasseur, Nasrin
Di Fiore, Frédéric
Clatot, Florian
SpringerLink (Online service)

Other Objects (12)

Aufsatzsammlung

Aromatase inhibitors

Aufsatzsammlung

Aromatase inhibitors

Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy

Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer

Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

Aromatase inhibitors in post-menopausal endometriosis

Heft

The Relapse

STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Aufsatzsammlung

Aromatase inhibitors

Aufsatzsammlung

Aromatase inhibitors

Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy

Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer

Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

Aromatase inhibitors in post-menopausal endometriosis

Heft

The Relapse

STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Aufsatzsammlung

Aromatase inhibitors

Aufsatzsammlung

Aromatase inhibitors

Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy

Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer

Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

Aromatase inhibitors in post-menopausal endometriosis

Heft

The Relapse

STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Aromatase inhibitors

Aromatase inhibitors

Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy

Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer

Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

Aromatase inhibitors in post-menopausal endometriosis

The Relapse

STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Aromatase inhibitors

Aromatase inhibitors

Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy

Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer

Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

Aromatase inhibitors in post-menopausal endometriosis

The Relapse

STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Aromatase inhibitors

Aromatase inhibitors

Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy

Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer

Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

Aromatase inhibitors in post-menopausal endometriosis

The Relapse

STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Related objects

Reset password